Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

OBJECTIVE: We sought to establish the performance of cell-bound complement activation products (CB-CAPs) as a diagnostic tool to distinguish primary fibromyalgia (FM) from systemic lupus erythematosus (SLE). METHODS: A total of 75 SLE and 75 primary FM adult subjects who fulfilled appropriate classi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lupus Sci Med
Autores principales: Wallace, Daniel J, Silverman, Stuart L, Conklin, John, Barken, Derren, Dervieux, Thierry
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2016
Materias:
Biomarker Studies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746498/
https://ncbi.nlm.nih.gov/pubmed/26870391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2015-000127
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares